Nifty
Sensex
:
:
11075.90
37104.39
93.10 (0.85%)
-209.45 (-0.56%)

Pharmaceuticals & Drugs

Rating :
76/99

BSE: 524742 | NSE: CAPLIPOINT

435.45
13-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  448.35
  •  448.35
  •  432.00
  •  442.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9835
  •  43.05
  •  519.00
  •  296.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,298.78
  • 17.42
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,146.33
  • 0.50%
  • 4.88

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.03%
  • 1.66%
  • 17.18%
  • FII
  • DII
  • Others
  • 0.03%
  • 0.00%
  • 12.10%

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 17.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 13.19

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 22.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.68
  • 32.18
  • 31.60

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.59
  • 13.66
  • 12.69

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.18
  • 21.72
  • 21.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
192.55
146.46
31.47%
187.34
143.41
30.63%
159.03
141.61
12.30%
155.86
131.31
18.70%
Expenses
125.17
93.43
33.97%
122.58
94.69
29.45%
101.27
90.82
11.51%
100.08
81.95
22.12%
EBITDA
67.38
53.03
27.06%
64.76
48.72
32.92%
57.76
50.79
13.72%
55.78
49.36
13.01%
EBIDTM
34.99%
36.21%
34.57%
33.97%
36.32%
35.87%
35.79%
37.59%
Other Income
4.47
1.61
177.64%
2.67
2.90
-7.93%
7.74
2.33
232.19%
7.01
3.58
95.81%
Interest
0.01
0.01
0.00%
0.01
0.01
0.00%
0.02
0.02
0.00%
0.02
0.02
0.00%
Depreciation
7.39
5.45
35.60%
6.72
6.18
8.74%
5.67
4.53
25.17%
5.58
4.45
25.39%
PBT
64.45
49.17
31.08%
60.69
45.43
33.59%
59.81
48.58
23.12%
57.20
48.47
18.01%
Tax
14.38
11.78
22.07%
10.84
10.13
7.01%
14.00
11.10
26.13%
13.70
12.94
5.87%
PAT
50.07
37.39
33.91%
49.86
35.29
41.29%
45.81
37.48
22.23%
43.50
35.54
22.40%
PATM
26.00%
25.53%
26.61%
24.61%
28.80%
26.47%
27.91%
27.06%
EPS
6.64
4.95
34.14%
6.59
4.68
40.81%
6.06
4.97
21.93%
5.75
4.71
22.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Net Sales
694.78
648.69
539.84
401.65
238.72
251.77
173.09
127.03
107.22
80.78
Net Sales Growth
23.45%
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
32.73%
 
Cost Of Goods Sold
309.86
288.78
238.18
184.93
121.16
135.62
102.58
84.45
77.36
60.88
Gross Profit
384.92
359.91
301.66
216.72
117.56
116.15
70.50
42.58
29.85
19.89
GP Margin
55.40%
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
24.62%
Total Expenditure
449.10
416.84
344.52
276.84
174.51
192.06
136.90
104.68
96.06
71.58
Power & Fuel Cost
-
13.76
10.98
9.91
7.56
8.61
3.07
1.12
0.84
0.68
% Of Sales
-
2.12%
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
0.84%
Employee Cost
-
45.58
37.61
29.71
17.92
18.24
12.63
7.69
6.28
4.14
% Of Sales
-
7.03%
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
5.13%
Manufacturing Exp.
-
43.49
37.11
28.56
14.33
16.04
7.42
3.07
1.63
1.54
% Of Sales
-
6.70%
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
1.91%
General & Admin Exp.
-
20.82
14.54
13.78
8.15
7.97
6.54
4.67
3.58
3.00
% Of Sales
-
3.21%
2.69%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
3.71%
Selling & Distn. Exp.
-
2.08
6.01
9.41
2.29
2.85
1.46
1.02
0.91
0.67
% Of Sales
-
0.32%
1.11%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
0.83%
Miscellaneous Exp.
-
2.33
0.10
0.55
3.10
2.72
3.19
2.66
5.44
0.66
% Of Sales
-
0.36%
0.02%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
0.82%
EBITDA
245.68
231.85
195.32
124.81
64.21
59.71
36.19
22.35
11.16
9.20
EBITDA Margin
35.36%
35.74%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
11.39%
Other Income
21.89
19.03
12.67
9.96
3.66
3.03
3.72
2.10
2.51
2.55
Interest
0.06
0.58
0.61
0.52
0.34
0.97
0.68
0.77
1.26
1.20
Depreciation
25.36
23.43
19.00
13.30
7.48
8.38
3.54
1.54
1.24
2.32
PBT
242.15
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Tax
52.92
50.32
43.74
25.44
14.28
12.26
9.76
8.12
3.14
1.91
Tax Rate
21.85%
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
23.24%
PAT
189.24
176.56
144.78
95.61
45.77
41.04
25.85
13.98
8.01
6.28
PAT before Minority Interest
189.38
176.56
144.63
95.50
45.77
41.13
25.93
14.02
8.03
6.31
Minority Interest
0.14
0.00
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
-0.03
PAT Margin
27.24%
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
7.77%
PAT Growth
29.88%
21.95%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
27.55%
 
Unadjusted EPS
25.04
23.35
19.26
12.65
30.28
27.16
17.11
9.25
5.30
4.16

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Shareholder's Funds
632.91
363.83
224.76
128.14
93.19
61.74
43.14
33.58
29.08
Share Capital
15.13
15.12
15.12
15.11
15.11
15.11
15.11
15.11
15.11
Total Reserves
610.93
345.42
209.56
111.40
78.08
46.63
28.03
18.47
13.97
Non-Current Liabilities
23.42
27.86
19.90
13.69
10.39
10.42
8.66
4.29
1.82
Secured Loans
0.29
0.32
0.48
0.73
0.88
2.07
3.48
1.55
0.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.40
1.63
0.82
0.81
0.38
0.27
0.20
Current Liabilities
86.11
108.67
113.36
125.04
124.97
107.58
83.01
69.20
40.44
Trade Payables
60.47
94.23
78.60
55.71
41.56
31.50
25.64
21.26
17.06
Other Current Liabilities
24.20
12.66
33.09
60.39
72.11
66.42
50.85
38.33
10.71
Short Term Borrowings
0.00
0.00
0.00
0.00
0.05
0.05
0.05
5.20
9.46
Short Term Provisions
1.44
1.78
1.67
8.94
11.25
9.60
6.47
4.41
3.22
Total Liabilities
742.52
500.45
358.38
267.14
228.82
179.92
134.90
107.12
71.37
Net Block
226.84
169.48
151.83
144.23
113.13
102.24
32.71
27.54
24.95
Gross Block
271.51
231.79
195.15
180.76
142.71
123.06
50.06
43.36
39.53
Accumulated Depreciation
44.67
62.31
43.31
36.53
29.58
20.82
17.36
15.82
14.58
Non Current Assets
248.83
237.46
179.16
148.61
146.95
131.30
96.21
53.41
30.12
Capital Work in Progress
9.70
15.29
3.42
0.23
30.63
24.54
48.98
12.79
0.17
Non Current Investment
0.33
41.45
13.24
0.44
0.45
0.44
1.19
1.14
1.15
Long Term Loans & Adv.
11.95
11.23
10.67
3.71
2.75
3.67
10.83
11.94
3.85
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
493.69
263.00
179.22
118.53
81.87
48.61
38.70
53.71
41.25
Current Investments
69.62
5.22
4.20
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
37.45
28.46
22.29
18.81
13.66
9.79
10.42
6.38
5.50
Sundry Debtors
159.81
125.88
33.02
7.95
5.66
0.09
0.86
7.28
8.33
Cash & Bank
152.99
79.28
93.07
68.10
45.37
26.82
16.84
31.80
21.62
Other Current Assets
73.83
6.88
7.32
11.09
17.18
11.90
10.57
8.25
5.80
Short Term Loans & Adv.
64.61
17.28
19.31
12.58
11.08
8.16
5.61
4.50
3.44
Net Current Assets
407.58
154.33
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
0.81
Total Assets
742.52
500.46
358.38
267.14
228.82
179.91
134.91
107.12
71.37

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Cash From Operating Activity
83.42
66.48
67.61
42.40
49.88
59.83
31.95
27.92
14.25
PBT
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Adjustment
19.12
14.83
8.61
3.87
6.21
2.14
-0.21
-0.25
2.06
Changes in Working Capital
-120.06
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
4.49
Cash after chg. in Working capital
125.94
102.83
91.16
58.78
61.56
67.15
37.75
29.81
14.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-42.51
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
-0.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-100.46
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
-6.90
Net Fixed Assets
58.45
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
-120.03
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
-38.88
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
89.79
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
-0.37
Net Cash Inflow / Outflow
72.76
-14.14
24.76
22.73
18.55
9.99
-14.97
10.18
6.98
Opening Cash & Equivalents
77.17
91.31
66.55
45.37
26.82
16.84
31.80
21.62
14.64
Closing Cash & Equivalent
150.65
77.17
91.31
68.10
45.37
26.82
16.84
31.80
21.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Book Value (Rs.)
82.78
47.69
29.73
16.25
11.84
7.68
5.22
3.95
3.36
ROA
28.41%
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
8.84%
ROE
35.79%
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
24.90%
ROCE
45.59%
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
26.87%
Fixed Asset Turnover
2.58
2.53
2.14
1.48
1.89
2.00
2.73
2.61
2.04
Receivable days
80.37
53.72
18.62
10.40
4.17
1.00
11.66
26.30
37.63
Inventory Days
18.54
17.16
18.68
24.83
17.00
21.31
24.06
20.01
24.84
Payable days
65.76
89.66
88.17
103.48
69.75
79.69
85.60
79.07
88.42
Cash Conversion Cycle
33.15
-18.78
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
-25.95
Total Debt/Equity
0.00
0.00
0.00
0.02
0.02
0.06
0.12
0.23
0.38
Interest Cover
391.22
309.72
235.08
179.35
56.11
53.29
29.73
9.88
7.84

News Update:


  • Caplin Point Lab - Quarterly Results
    12th Aug 2019, 16:39 PM

    Read More
  • Caplin Point Laboratories’ arm receives EIR for Injectable facility
    25th Jul 2019, 11:41 AM

    USFDA has completed inspection at Caplin Steriles’ Injectable site at Gummidipoondi between June 6 and June 14, 2019

    Read More
  • Caplin Point Laboratories’ arm gets USFDA’s nod for Tranexamic Acid Injection
    18th Jul 2019, 12:01 PM

    The company’s arm has developed and filed 11 ANDAs on its own and with partners

    Read More
  • USFDA completes inspection at Caplin Point Laboratories’ Steriles Injectable site
    17th Jun 2019, 11:41 AM

    At the end of this scheduled GMP inspection, there were only two observations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.